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Summary
Covalent modification by SUMO regulates a wide range
of cellular processes, including transcription, cell cy-
cle, and chromatin dynamics. To address the biologi-
cal function of the SUMO pathway in mammals, we gen-
erated mice deficient for the SUMO E2-conjugating
enzyme Ubc9. Ubc9-deficient embryos die at the early
postimplantation stage. In culture, Ubc9 mutant blas-
tocysts are viable, but fail to expand after 2 days and
show apoptosis of the inner cell mass. Loss of Ubc9
leads to major chromosome condensation and segre-
gation defects. Ubc9-deficient cells also show severe
defects in nuclear organization, including nuclear en-
velope dysmorphy and disruption of nucleoli and PML
nuclear bodies. Moreover, RanGAP1 fails to accumu-
late at the nuclear pore complex in mutant cells that
show a collapse in Ran distribution. Together, these
findings reveal a major role for Ubc9, and, by implica-
tion, for the SUMO pathway, in nuclear architecture and
function, chromosome segregation, and embryonic vi-
ability in mammals.
Introduction
Posttranslational modification of proteins is an impor-
tant regulatory mechanism of protein function. Modifica-
tion by SUMO (small ubiquitin-related modifier) is un-
usual in that the modifier itself is a small polypeptide.
Sumoylation has been involved in many different cell reg-
ulatory processes, and the consequences of this modi-
fication seem to be as diverse as its targets (for reviews,
see Hay, 2005; Johnson, 2004; Mu¨ller et al., 2001; Seeler
and Dejean, 2003). Sumoylation is a highly evolution-
ary conserved pathway from yeast to humans. SUMO
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ical School, Piscataway, New Jersey 08854.is covalently attached to lysines in substrate proteins
by a series of enzymatic reactions similar to those in-
volved in ubiquitination. SUMO is first activated by the
E1-activating enzyme, the Aos1/Uba2 heterodimer; sub-
sequently transferred to the unique E2 enzyme, Ubc9;
and conjugated to substrates in a reaction that is cata-
lyzed by a variety of E3 enzymes such as the PIAS family
members (Johnson and Gupta, 2001; Sachdev et al.,
2001; Takahashi et al., 2001), the RanBP2 nucleoporin
(Pichler et al., 2002), or the polycomb protein Pc2 (Kagey
et al., 2003). SUMO is removed from substrates in re-
actions catalyzed by a family of isopeptidases called
SENPs.
In S. cerevisiae, Ubc9-depleted cells arrest in G2/M
phase, causing the accumulation of large budded cells
with a single nucleus, a short spindle, and replicated DNA
(Seufert et al., 1995). By contrast, in S. pombe, hus5
(Ubc9 homolog) deletion is viable, but cells are severely
impaired in growth and exhibit high levels of abortive
mitosis and chromosome missegregation (al-Khodairy
et al., 1995), a phenotype closely resembling that of
pmt3 (SUMO homolog) loss (Tanaka et al., 1999). Ubc9
orSUMORNAi knockdown experiments inC. elegans re-
sult in embryonic arrest after gastrulation and pleiotropic
defects in larval development such as vulval eversion
at the fourth larval stage and abnormal tail morphology
(Jones et al., 2002). In D. melanogaster, the Ubc9 le-
thal mutant, also known as lesswright, dominantly sup-
presses the nondisjunction and cytological defects of
female meiotic mutations that affect spindle formation
(Apionishev et al., 2001). Another fly Ubc9 mutation,
termed semushi, blocks nuclear import of Bicoid during
embryogenesis and results in misregulation of the seg-
mentation genes that are Bicoid targets with consequent
loss of the anterior half of the larval body structure (Epps
and Tanda, 1998). Conditional depletion of Ubc9 in
chicken DT40 cells leads to an increase in the number of
cells containing multiple or fragmented nuclei, with most
of these cells dying by apoptosis (Hayashi et al., 2002).
To investigate the role of the SUMO system in mam-
mals, we generated mice deficient for the Ubc9 protein.
We find that Ubc9 is essential, and that Ubc9-deficient
embryos die early in development, subsequent to the
blastocyst stage and prior to E7.5. In culture, mutant blas-
tocysts are viable up to 2 days, but they subsequently
die of apoptosis. Mutant cells show chromosome de-
fects and gross alterations in nuclear organization such
as disassembled nucleoli and PML Nuclear Bodies, mis-
shapen nuclei, as well as mislocalized RanGAP1 and
Ran. Together, our findings indicate that Ubc9, and, by
implication, the SUMO pathway, are crucial for proper
nuclear architecture, for accurate chromosome segre-
gation, and for embryonic viability.
Results
Disruption of the Murine Ubc9 Gene
The murine Ubc9 gene consists of 7 exons that encode
a 158 amino acid protein that is 100% identical to human
Ubc9 (Figure 1A). To inactivate the murine Ubc9 gene,
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Figure 1. Inactivation of the Ubc9 Locus via
Cre-Mediated Gene Inversion
(A) Diagram of the wild-type Ubc9 genomic
locus (+), the targeting vector, the targeted
allele (t), the functional floxed allele (fl), and
the inverted null allele (inv). The inverted allele
is generated by simultaneous deletion of the
neo gene and inversion of the loxP-flanked
exon 2 and 3 region. White boxes, 50 and 30
UTRs; black boxes, coding sequences; ar-
rowheads, loxP sites. E, EcoR1; X, Xba1;
Neo, neomycin-resistant gene. The location
of the 50 and 30 Southern probes is given
along with the expected sizes in kilobases
(kb) of the hybridizing EcoR1 and Xba1 frag-
ments. Arrows and letters indicate the posi-
tion of PCR primers used for genotyping.
Matings with PGK-Crem transgenic mice and
wild-type mice are indicated.
(B) Southern blot analysis of wild-type (+/+)
and targeted (+/t) ES cells. EcoR1- and Xba1-
digested DNAs were hybridized with the 50
and 30 probes as shown. Expected sizes are
indicated in kb.
(C) Representative genotypic analysis of mice
generated by breedingUbc9fl-inv/+/PGK-Crem
animals with wild-type mice. DNA samples
were subjected to PCR with the primer pairs
a/b and a/c andCre as shown in (A). The geno-
type of the Ubc9inv/+ mice harboring simulta-
neous deletion of the neo gene and stabilized
inversion of the loxP-flanked region sub-
sequent to the removal of the Cre transgene
that were selected for the generation of
Ubc9inv/inv animals is boxed. The expected
PCR products for the floxed (fl) and for the
wild-type (+) alleles are indicated.
(D) Levels of Ubc9 in testis from Ubc9+/+ and
Ubc9inv/+ mice. Western blot was performed
with anti-Ubc9 and anti-tubulin (Tub) anti-
bodies as a control.we used the flox-and-invert strategy in which the flank-
ing loxP sites are in opposite orientation, thus permitting
Cre recombinase-mediated inversion. The advantage of
this strategy is to provide an amenable system for the
generation of mice expressing a quarter dose of Ubc9,
an approach successfully used in the context of lym-
phoid cell function (Lam and Rajewsky, 1998) and can-
cer modeling (Roberts et al., 2002). The inverted allele,
designatedUbc9inv, was generated with a targeting vec-
tor in which a DNA segment containing exons 2 and 3
was flanked by two loxP sites in opposite orientation
(Figure 1A). Three clonalUbc9-targeted EScell lines were
produced, and appropriate integration was checked by
Southern blot (Figure 1B). When injected into blasto-
cysts, two of these yielded chimeras that gave germline
transmission. Ubc9t/t homozygous males were crossed
with PGK-Crem females (Lallemand et al., 1998) that
express Cre from oogenesis onward to generate
Ubc9fl-inv/+/PGK-Crem animals. Since the Cre-mediated
inversion reaction is entirely reversible and functions
equally well in both directions, an equal ratio of floxed
inverted (Ubc9inv) and noninverted (Ubc9fl) alleles will
be obtained in vivo as long as Cre is present in the cells
(Figure 1A). To get stably inverted Ubc9 alleles, the Cre
transgene was removed by crossing Ubc9fl-inv/+/PGK-
Crem mice with wild-type animals.Ubc9inv/+ mice harboring simultaneous deletion of the
neomycin gene and constitutive inversion of the loxP-
flanked region (Figure 1C) were born at expected fre-
quencies, and they were viable and fertile and showed
no overt phenotype. Analysis of peripheral blood re-
vealed an increase in both circulating lymphocytes
(Ubc9+/+, 4.03 6 0.53 3 103 cells/ml ; Ubc9inv/+, 6.43 6
1.16 3 103 cells/ml, p = 0.0007) and granulocytes
(Ubc9+/+, 1.03 6 0.54 3 103 cells/ml; Ubc9inv/+, 2.33 6
0.93 3 103 cells/ml, p = 0.0272), as well as a slight but
significant increase in glycemia (Ubc9+/+, 8.28 6 0.39
mmol/l;Ubc9inv/+, 9.836 0.35 mmol/l, p = 0.0083). These
alterations did not, however, compromise life span, at
least within the 2 year observation period. Western blot
analysis showed that the amount of both the free form
and the SUMO bound form of Ubc9 in various tissues
from Ubc9inv/+ animals is roughly half that expressed in
wild-type (Figure 1D and data not shown). These data in-
dicate that theUbc9inv allele is null, and that no compen-
satory mechanism arose in the hemizygotes.
Expression from One Ubc9 Allele Is Sufficient
for Normal Sumoylation
We next sought to determine if the general SUMO path-
way is affected in hemizygous mice. The global pattern
of SUMO-1 conjugates as detected by Western blot with
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771an anti-SUMO-1 antibody was unchanged in Ubc9inv/+
mice when compared to their normal littermates (Figure
2A). At the level of single SUMO substrates, such as
RanGAP1 and PML for which endogenous sumoylated
forms are easily detectable, again, the ratio of modified
versus unmodified protein was identical inUbc9inv/+ and
wild-type animals, indicating that the sumoylation status
of these two major substrates is not affected when
the level of Ubc9 expression is decreased by one-half
(Figure 2A).
While, in mammalian cells, most of SUMO-1 is conju-
gated to its substrates, SUMO-2 and SUMO-3 exist pri-
marily as free forms that are subject to massive conjuga-
tion upon stress (Saitoh and Hinchey, 2000). To test the
functionality of the SUMO-2/3 pathway upon cellular
stress in hemizygous mice, we monitored the activation
of SUMO-2/3 conjugation in Ubc9inv/+ fibroblasts after
ethanol addition, osmotic stress, oxidative stress, and
heat shock. Western blot analysis of cell extracts sub-
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Figure 2. Deletion of One Ubc9 Allele Has No Significant Effect on
Overall Sumoylation
(A) Western blots for SUMO-1, RanGAP1, and PML from wild-type
(+/+) and hemizygous (inv/+) mice testis lysates. The positions of
unmodified and modified substrate proteins are indicated. Cross-
reacting bands with the anti-RanGAP1 and anti-PML antibodies
are marked by an asterisk. Tubulin levels were measured to ensure
equal loading.
(B) Stress-induced modifications by SUMO-2/3 are similar inUbc9+/+
andUbc9inv/+ mice. Western blot ofUbc9+/+ andUbc9inv/+ adult fibro-
blasts subjected to protein-damaging stimuli and blotted for SUMO-
2/3 (upper panel). No stress, Control; ethanol, EtOH; osmotic stress,
Osm; oxidative stress, Oxi; and heat shock, Heat. The 18 kDa band in
all lanes (middle panel) corresponds to the nonconjugated pool of
SUMO-2/3.jected to these stresses showed a similar accumulation
of SUMO-2/3 conjugates in Ubc9inv/+ mice compared
to wild-type animals, with heat shock showing more
dramatic changes than the other stresses (Figure 2B).
Thus, Ubc9inv/+ mice have a normal capacity to respond
to acute sumoylation signals. However, it is noteworthy
that, whereas the global pattern of SUMO-1 conjugates
seems unchanged between Ubc9inv/+ and Ubc9+/+ mice
(Figure 2A), the steady-state level of SUMO-2/3 conju-
gates appears slightly reduced in Ubc9inv/+ fibroblasts,
whether subjected to stress or not, resulting in an in-
crease in the pool of free SUMO-2/3 in these cells (Figure
2B). This suggests that conjugation of SUMO-2/3 to tar-
get proteins may be more subject to control by the Ubc9
expression level than modification with SUMO-1.
Ubc9 Is Essential for Embryonic Viability
To generate homozygous Ubc9-deficient mice,Ubc9inv/+
mice were intercrossed. Of 291 live births analyzed by
PCR, no homozygous Ubc9inv/inv mice were observed
when using either of the two founder lines. This finding
indicates that loss of Ubc9 leads to embryonic lethality
(Table 1). To determine whenUbc9inv/inv mice die in utero,
we analyzed embryos at embryonic days (E) 13.5, 9.5,
and 7.5. No homozygous mutant embryos were recov-
ered at any stage, indicating thatUbc9inv/inv embryos die
prior to E7.5. However, the high number of deciduas-
containing embryos in the final stage of resorption
(more than a quarter of total embryos) suggested that
Ubc9inv/inv embryos survive earlier stages of develop-
ment and implant before degenerating. To test whether
Ubc9-deficient embryos indeed survive to the blastocyst
stage, embryos at E3.5 were collected and genotyped.
Ubc9inv/inv blastocysts, which were undistinguishable
from wild-type and heterozygous embryos (Figure 3A),
were recoveredat theexpected Mendelian ratio (Table 1).
Thus, Ubc9inv/inv embryos successfully develop to the
blastocyst stage, undergo uterine implantation, and die
subsequently, presumably as cellular pools of mater-
nally derived Ubc9 mRNA and protein decline.
To further analyze the ability of mutant embryos to
form blastocyst outgrowths in vitro, E3.5 blastocysts
isolated from Ubc9inv/+ intercrosses were grown in cul-
ture for 4 days (Figure 3A) and then genotyped. After
1 day in culture, Ubc9+/+, Ubc9inv/+, and Ubc9inv/inv blas-
tocysts hatched from the zona pellucida and attached
onto the culture dishes, and trophoblast giant cells
Table 1. Viability Analysis of Ubc9inv/inv Mice and Embryos
Number with Genotypea
Stage +/+ inv/+ inv/inv Resorbedb Total
Live birth line 196 67 112 0 179
Live birth line 134 43 69 0 112
Embryos, E13.5 3 10 0 8 21
Embryos, E9.5 7 16 0 12 35
Embryos, E7.5 9 21 0 14 44
Blastocysts, E3.5 8 23 9 40
Cultured blastocysts 37 96 47 180
a Genotypes were determined by PCR as described in Experimental
Procedures.
b Empty deciduas were scored as ‘‘Resorbed.’’ Embryos from line
134 were selected for developmental studies.
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Figure 3. Deletion of Ubc9 Leads to Apoptotic Death of Early Embryonic Cells
(A) Outgrowth of Ubc9+/+, Ubc9inv/+, and Ubc9inv/inv embryos. E3.5 blastocysts from Ubc9inv/+ intercrosses were cultured in vitro for 4 days.
Arrows point to the ICM, and trophoblastic giant cells (TGC) are indicated. Genotypes were determined by PCR afterward. The scale bars rep-
resent 50 mm.
(B) Mean number of TUNEL-positive apoptotic ICM cells per embryo. E3.5 blastocysts were isolated fromUbc9inv/+ intercrosses and cultured for
3 days. Statistical analyses (ANOVA) were performed by using the PLSD Fisher test. Error bars denote standard errors, and asterisks indicate
significant difference, p < 0.01. n, number of embryos analyzed.
(C) TUNEL staining of Ubc9inv/inv E3.5 blastocysts cultured for 2 days. Phase contrast, fluorescein (TUNEL), and merged images are shown. The
arrow points to the ICM, and TGC is indicated.spread around a central inner cell mass (ICM). At isola-
tion and during the first day in culture, the ICM of mutant
blastocysts was morphologically indistinguishable from
that of wild-type and heterozygous blastocysts. How-
ever, at day 2 in culture, the ICM of Ubc9inv/inv embryos
was disorganized and severely reduced in size, and vir-
tually no Ubc9inv/inv ICM cells persisted at day 4 (Figure
3A). In contrast, the nondividing trophoblastic giant cells
of Ubc9inv/inv embryos remained after 4 days in culture
and showed a normal appearance, suggesting that
they were still alive (Figure 3A). Altogether, the develop-
mental defects of Ubc9 mutant embryos in vivo and
in vitro indicate that the SUMO pathway is essential for
growth of the ICM in the postimplantation phase of
development.
Selective Apoptosis of Inner Cell Mass
in Ubc9 Mutant Embryos
To next investigate whether such ICM regression in
Ubc9-deficient embryos was due to increased apopto-
sis, we performed a TUNEL assay on E3.5 blastocysts
cultured for 1–3 days. While the average number ofTUNEL-positive cells per embryo was low in wild-type
and heterozygous embryos, this number significantly
increased in mutant ICM cells after 2 days and remained
high up to 3 days. Quantitation of apoptosis showed
about 5-fold more apoptotic cells inUbc9inv/inv ICM cells
than in the corresponding wild-type and heterozygous
cells at day 2 (Figure 3B). By contrast, only a few
TUNEL-positive signals could be detected in the Ubc9-
deficient trophoblastic cells, indicating that these cells
are not undergoing apoptosis (Figure 3C). We conclude
that loss of Ubc9 ultimately results in ICM apoptotic cell
death, whereas mutant future extraembryonic tissues
escape this death pathway.
Loss of Ubc9 Leads to Mitotic Chromosome Defects
Given the proposed role of sumoylation in chromosome
organization, we examined mitotic cells in E3.5 blasto-
cysts cultured for 2 days. The mitotic index of each em-
bryo was determined by counting the fraction of cells
with condensed chromosomes. Though the total num-
ber of cells in the mutant blastocysts was reduced by
two-thirds when compared to that of the wild-type and
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Figure 4. Analysis of Chromosome Defects
in Ubc9-Deficient Embryos
Analysis was performed on unsynchronized
E3.5 blastocysts cultured for 2 days and
stained with DAPI.
(A) Comparison of the total number of DAPI-
stained cells in Ubc9+ (Ubc9+/+ and Ubc9inv/+)
and Ubc9inv/inv embryos. Statistical analysis
was performed by Mann-Whitney test. Error
bars denote standard errors, and the
asterisk indicates significant difference, p <
0.0001. n, number of embryos analyzed.
(B) Mitotic index for embryos of Ubc9+
(Ubc9+/+ and Ubc9inv/+) and Ubc9inv/inv geno-
types. The mitotic index (% of total) was de-
termined by counting cells with condensed
chromosomes. Statistical analysis was per-
formed by unpaired t test. Error bars denote
standard errors; n, number of embryos ana-
lyzed. The mean number of cells per Ubc9+
and Ubc9inv/inv embryo was 176 and 59,
respectively.
(C) Mean metaphase area (in mm2) for em-
bryos of Ubc9+ (Ubc9+/+and Ubc9inv/+) and
Ubc9inv/inv genotypes. The maximal area of
randomly orientated metaphases was framed
with rectangles and determined by Zeiss
Axiovision 4.1 software. Statistical analysis
was performed by using the Mann-Whitney
test. Error bars denote standard errors, and
the asterisk indicates significant difference,
p < 0.0001. n, number of metaphases ana-
lyzed.
(D–G) DAPI-stained mitotic cells. (D) and
(E) are wild-type embryos. (F) and (G) are
Ubc9inv/inv embryos. (D) and (F) show meta-
phase, and (E) and (G) show anaphase. The
scale bar represents 5 mm.
(H–M) Chromosome spreads. (H) Typical
chromosome spread from Ubc9+ embryos.
(I–M) Examples of chromosome defects in
Ubc9inv/inv embryos: (I) hypocondensation,
(J) breaks (closed arrowheads) or sister chro-
matid separation (open arrowheads), (K)
chromosome loss, (L) polyploidy, (M) multiple
defects: polyploidy, breaks (closed arrow-
heads), and chromatid separation (open arrowheads). The mean chromatid width was significantly higher in mutant compared to wild-type
cell spreads (1.340 6 0.27 mm versus 1.108 6 0.26 mm, Mann-Whitney Test, p = 0.002). Metaphase chromosomes displaying a width greater
than 1.372 mm, corresponding to the wild-type mean plus 1 SD width, were scored as hypocondensed. For Ubc9+, 42 cells from 14 blastocysts
were scored. For Ubc9inv/inv, 24 cells from 12 blastocysts were scored. Ten chromatids per metaphase, from different chromosomes, were mea-
sured to produce a chromatid mean width. Percentages ofUbc9inv/inv versus Ubc9+ for each defect are given with each panel. The scale bar rep-
resents 10 mm.heterozygous embryos (Figure 4A), the mitotic index
was almost the same (Figure 4B). In wild-type ICM cells,
mitosis appeared normal at metaphase (Figure 4D), and
chromosome masses separated properly in all ana-
phase cells (Figure 4E). By contrast, two major types
of chromosome defects were observed in the mutant
cells: (1) a significant increase in the size of nearly all
metaphase plates (Figures 4C and 4F), and (2) aberrantly
segregating chromosomes in anaphase characterized
by the presence of anaphase bridges inw10% of mitotic
cells (Figure 4G). Such aberrant anaphase chromo-
somes were never observed in Ubc9inv/+ and Ubc9+/+
cells. Examination of DAPI-stained mitotic chromosome
spreads from wild-type and mutant blastocysts blocked
with nocodazole further revealed that mutant cells har-
bor significantly elevated numbers of chromosomes that
are hypocondensed (Figure 4I), broken, or, in which sis-
ter chromatids are separated (Figure 4J), or lost (Figure4K). Furthermore, approximately one-third of the mutant
cells exhibited polyploidy (Figure 4L), and almost half
of the cells displayed more than one of the above-
described defects (Figure 4M). The elevated frequency
of mitotic defects in Ubc9-deficient ICM cells indicates
that sumoylation is critical for structure as well as for
proper segregation and inheritance of chromosomes.
Nuclear Organization Defects in Ubc9 Mutant Cells
We expected that the absence of Ubc9 would have an
effect on the subcellular localization of the SUMO pro-
teins. In wild-type cells, SUMO-1, which is mostly conju-
gated to its substrates, displayed its typical nuclear dif-
fuse and speckled localization (Figures 5A and 5B). By
contrast, in Ubc9-deficient cells, SUMO-1 became dif-
fusely distributed both in the nucleus and the cytoplasm,
as expected for nonconjugated SUMO-1 (Figures 5C
and 5D). A similar mislocalization of SUMO-1 has been
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Figure 5. Abnormal Nuclear and Subnuclear
Architecture in Ubc9-Deficient Cells
Microscopy analysis ofUbc9+/+ andUbc9inv/inv
E3.5 blastocysts cultured for 2 days.
(A–T) Cells were revealed with antibodies for
the indicated nuclear proteins and merged
with DAPI: (A–D) SUMO-1, (E–H) Lamin B1,
(I–L) fibrillarin, (M–P) PML, and (Q–T) Daxx.
In (G), note the dense foci of lamin B (arrow),
and in (H), note the condensed chromatin
masses that were not surrounded by a visible
lamina (arrowhead). In (L), note the cap-like
structures dissociated from condensed chro-
matin areas (arrows).
(U and V) Images from phase contrast micros-
copy. The scale bar represents 10 mm.observed in cells overexpressing subdomains of the
Ubc9-interacting RanBP2 nucleoporin (Saitoh et al.,
2002).
To further assess the effect of Ubc9 ablation at the cel-
lular level, we examined the integrity of specific nuclear
and subnuclear structures in Ubc9+/+ and Ubc9inv/inv
embryos. Nuclear morphology was investigated by us-
ing an anti-lamin B1 antibody. When compared to their
wild-type counterparts, Ubc9-deficient cells exhibited
oversized interphase nuclei, which appeared to be highly
dysmorphic and showed invaginations, herniations,
and blebbing (Figures 5E–5H). In a subset of cells, con-
densed chromatin masses were present that were not
surrounded by a visible lamina (arrowhead in Figure 5H).
In these cells, lamin B1 labeling was either diffuse in the
cytoplasm or present in dense foci, evoking lamin ag-
gregation (arrow in Figure 5G).
We then used two other markers to study the fate
of well-characterized subnuclear structures in Ubc9-
deficient cells, namely, fibrillarin for the nucleoli and PMLfor the PML Nuclear Bodies. When compared to the
typical large nucleoli present in the wild-type cells, in
more than 90% of mutant cells, fibrillarin is distributed
in several foci, suggesting that functional nucleoli are not
present (Figures 5I–5L). The cap distribution close to the
DAPI-negative structure indicates fragmented nucleolar
structures (arrows in Figure 5L). This disorganization,
which was further confirmed by phase contrast micros-
copy (Figures 5U and 5V), is reminiscent of the nucleolar
disassembly that occurs when rDNA transcription is in-
hibited (Hernandez-Verdun et al., 2002). Similarly, the
PML Nuclear Bodies were disrupted in Ubc9inv/inv cells
(Figures 5M–5P). This feature recalls the pattern ob-
served in PML2/2 cells overexpressing a sumoylation-
deficient PML protein (Zhong et al., 2000). To further
confirm the complete disruption of the PML Nuclear
Bodies, we analyzed the localization of the Daxx protein,
a transcriptional repressor that is recruited to the Nu-
clear Bodies via its association with SUMO-modified
PML (Ishov et al., 1999). In Ubc9+/+ cells, Daxx localized
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Figure 6. Alteration in RanGAP1 and Ran
Distribution in Ubc9-Deficient Cells
(A–P) Microscopy analysis of Ubc9+/+ and
Ubc9inv/inv E3.5 blastocysts cultured for 2
days. Cells were stained with antibodies for
either (A, C, E, and G) RanGAP1 and merged
with DAPI stain for (B, D, F, and H) nuclei or
(I, K, M, and O) Ran and merged with DAPI
stain for (J, L, N, and P) nuclei. Photos were
taken from a single Ubc9+/+ or Ubc9inv/inv em-
bryo at two different focal planes corre-
sponding to the ICM (left panels) and TGC
(right panels). The arrows in (G) point to
Ubc9inv/inv TGC cells, which still showed
association of RanGAP1 with the nuclear en-
velope. The scale bar represents 20 mm.specifically in the Nuclear Bodies together with PML
(Figure 5Q and data not shown). However, in Ubc9inv/inv
cells, Daxx was detected in a nuclear diffuse and patchy
distribution characteristic of its condensed chromatin lo-
cation (Figures 5S and 5T), similar to what was observed
in MEFs disrupted for PML Nuclear Bodies (Ishov et al.,
1999). Altogether, these data indicate that impairment
of the SUMO pathway induces drastic abnormalities in
nuclear and subnuclear architecture that are likely detri-
mental for cell survival.
Mislocalization of RanGAP1 and Ran
in Ubc9 Mutant Cells
The first identified substrate for SUMO was RanGAP1,
the GTPase-activating protein for Ran, which is required
for the bidirectional transport of proteins across the
nuclear pore complex. Given that the association of
RanGAP1 with the nuclear pore complex (NPC) RanBP2
protein was shown to depend on RanGAP1 sumoylation
(Mahajan et al., 1998; Matunis et al., 1998), we examined
the consequences of the impairment of sumoylation on
RanGAP1 localization. Immunofluorescence micros-
copy on Ubc9+/+ ICM cells and trophoblastic giant cells
predominantly revealed an intense nuclear rim staining
demonstrating the association of RanGAP1 with the nu-
clear envelope (Figures 6A, 6B, 6E, and 6F). As could be
expected, in the null embryos, RanGAP1 remained dif-
fusely distributed throughout the cytosol of ICM cells
and failed to accumulate at the NPC (Figures 6C and
6D). It is noteworthy that, while the mislocalization of
RanGAP1 is evident in all cells from the ICM, some of
the trophoblastic giantUbc9inv/inv cells showed a nuclear
rim staining (Figures 6G and 6H), indicating that these
cells retained their ability to concentrate RanGAP1 at
the nuclear envelope. Consistent with previous findings
(Zhang et al., 2002), Ubc9 was found to partially concen-
trate at the rim of the nuclear envelope in the wild-type
embryos (Figures S1B and S1D; see the Supplemental
Data available with this article online). By contrast, the
low amount of remaining maternal Ubc9 was dispersed
in the cytoplasm of every cell from Ubc9-deficient E5.5embryos, except in the few trophoblastic giant cells that
retained accumulation of RanGAP1 at the NPC (Figures
S1E–S1H). Given that the maternal pool of Ubc9 de-
creased to the same extent in the ICM and the tropho-
blastic Ubc9inv/inv cells, this suggests that the persis-
tence of RanGAP1 together with Ubc9 at the nuclear
envelope in some of the trophoblastic cells likely results
from a lower rate in nuclear envelope breakdown rather
than from a slower loss of maternal Ubc9 in these cells.
Thus, SUMO modification may be actively required
for proper targeting of RanGAP1 upon nuclear envelope
reformation.
An essential factor in protein trafficking through the
NPC is the Ran protein itself, which plays a key role in de-
termining the bidirectionality of nuclear transport (Gor-
lich and Mattaj, 1996; Pemberton and Paschal, 2005).
To examine whether the failure of RanGAP1 to accumu-
late at the NPC is associated with a perturbation in Ran
localization, we analyzed the subcellular distribution of
Ran in Ubc9 mutant cells. Whereas Ran was found to
be predominantly located in the nucleus in Ubc9+/+ cells
(Figures 6I and 6M), it was broadly distributed through-
out the nucleus and the cytoplasm of all ICM and most of
the trophoblastic Ubc9inv/inv cells (Figures 6K and 6O).
Given the central role of the Ran gradient in regulating
protein transport across the nuclear envelope, the high
levels of cytosolic Ran in Ubc9-deficient cells strongly
predict that these cells suffer profound defects in nucle-
ocytoplasmic trafficking.
Discussion
The SUMO modification pathway is a key regulator of nu-
merous cellular activities, including transcriptional reg-
ulation, nuclear transport, maintenance of genome in-
tegrity, and signal transduction (Hay, 2005; Johnson,
2004; Mu¨ller et al., 2001; Seeler and Dejean, 2003).
Here, we provide evidence that the SUMO system is es-
sential for early mammalian development. Its involve-
ment in chromosome structure and function is demon-
strated by condensation defects during metaphase and
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776defective anaphase movements. The major alterations
in nuclear membrane morphology and subnuclear struc-
tures reveal a major role for SUMO modification in nu-
clear organization. Moreover, perturbation in RanGAP1
and Ran distribution is predicted to severely affect nu-
clear transport. Our results also show that loss of Ubc9
leads to apoptosis of the ICM. Therefore, Ubc9 and, by
implication, the SUMO pathway, is critical for early em-
bryonic development, and lethality is most likely caused
by a combination of these defects.
Chromosome Defects in Ubc9-Deficient Cells
Several lines of evidence have substantiated a role for
SUMO modification in chromosome structure and func-
tion, but the molecular basis of these effects is largely
unknown. Anaphase segregation defects of chromo-
somes as well as aneuploidy in Ubc9inv/inv ICM cells
demonstrate a role for sumoylation in chromosome in-
heritance, whereas its involvement in chromosome
structure is illustratedbyhypocondensationduringmeta-
phase. These findings contrast with a previous study
in which inactivation ofUbc9 in chicken DT40 cells failed
to induce chromosome missegregation. Rather, cells
with multiple nuclei suggested defects in cytokinesis
(Hayashi et al., 2002). The elevated incidence of poly-
ploidy we observe inUbc9inv/inv cells may similarly reflect
a cytokinesis defect. Whether the absence of chromo-
some missegregation in chicken DT40 cells reflects a dif-
ference between embryonic cells and a transformed cell
line is not known. Nevertheless, a very similar phenotype
to that observed in murine Ubc9-deficient cells, includ-
ing chromosome condensation defects and anaphase
bridges, was reported in D. melanogaster mutated for
the Su(var)2-10 (PIAS homolog) gene (Hari et al., 2001).
In addition, S. pombe strains disrupted for the pmt3,
hus5, and pli1 genes (SUMO, Ubc9, and PIAS homo-
logs) show an increase in chromosome missegregation
(al-Khodairy et al., 1995; Tanaka et al., 1999; Xhemalce
et al., 2004). Similarly, inactivation of the ulp2/smt4
SUMO isopeptidase gene in S. cerevisiae leads to chro-
mosome segregation defects and altered chromosome
condensation. Notably, the mitotic-specific targeting of
the condensin complex to chromatin, in particular rDNA
chromatin, is impaired in ulp2mutant strains (Strunnikov
et al., 2001). Given that altering either SUMO conjugation
or deconjugation leads to similar chromosome pheno-
types, it is likely that a modification/demodification equi-
librium must be maintained for proper chromosome
structure and function.
A possible role for sumoylation in chromosome con-
densation is further supported by the recent finding
that sumoylation of the budding yeast Ycs4 condensin
subunit is stimulated by Cdc14, a phosphatase required
for rDNA segregation, raising the possibility that Cdc14
targets condensin to the rDNA by inducing sumoylation
of one of its subunits (D’Amours et al., 2004). Moreover,
Pds5, a protein important for sister chromatid cohesion
and condensation was found to be sumoylated, with
SUMO modification increasing during mitosis. Overex-
pression of Ulp2 suppresses the temperature sensitivity
of pds5mutants, suggesting that Pds5 sumoylation pro-
motes the dissolution of cohesion (Stead et al., 2003).
Conversely, in fission yeast, loss of Ulp2 leads to prema-
ture centromere separation and failure to maintain cohe-sion at centromeric regions. Excess in sumoylation of
topoisomerase II may in part account for these pheno-
types (Bachant et al., 2002). Similar conclusions were
reached with a dominant-negative mutant of Ubc9 in
Xenopus egg extracts (Azuma et al., 2003). Most of the
chromosome segregation defects associated with im-
pairment of the SUMO pathway in lower eukaryotic cells
are associated with diverse phenotypes, including
hypersensitivity to DNA damage, telomere length elon-
gation, and recombination defects. It remains to be de-
termined whether other chromosome processes, in ad-
dition to chromosome condensation and segregation,
are also affected by Ubc9 loss in mammalian cells.
Loss of Sumoylation Leads to Abnormal
Nuclear Architecture
Lack of SUMO modification disrupted the structure of
the nuclear envelope, producing grossly misshapen nu-
clei with multiple large blebs and abnormal chromatin
distribution. Such alterations of the nuclear peripheral
shape are reminiscent of the changes observed in lamin
B1-deficient murine embryo fibroblasts (Vergnes et al.,
2004). A similar budding of the nuclear envelope can also
be seen in cells committed to apoptosis (Buendia et al.,
1999; Kihlmark et al., 2001). In cells programmed to die,
caspase-dependent cleavage of lamins has been con-
sidered as a prelude to nuclear breakdown, and morpho-
logical modification of the nuclear envelope is recog-
nized as a hallmark of apoptosis (Lazebnik et al., 1995).
Thus, perturbation of the nuclear envelope in Ubc9-
deficient cells may simply be the manifestation of apo-
ptotic cell death. Alternatively, the state of lamin assem-
bly may also be involved in triggering apoptosis, as inhi-
bition of the assembly of lamin B induces cell death
(Steen and Collas, 2001). Whether lack of sumoylation
may result in a failure to correctly assemble the nuclear
lamina remains to be determined. Moreover, recent find-
ings have shown that Ran and its cofactors RanBP2,
RanGAP1, and RCC1 are all essential for nuclear enve-
lope assembly in vivo (Askjaer et al., 2002; Bamba et al.,
2002). Thus, mislocalization of RanGAP1 and Ran in
Ubc9-depleted cells might also contribute to the mor-
phological abnormalities of the nuclear envelope.
Our results also show that disruption of the SUMO
pathway results in nucleolar disassembly. Known for
several decades as the ribosome factory, the nucleolus
was recently shown to be also involved in several other
cellular processes, including chromatin architecture, in-
tranuclear trafficking, and cell cycle control (reviewed in
Hernandez-Verdun et al., 2002). A possibility is that dis-
ruption of nucleoli observed in Ubc9-deficient cells is
a direct consequence of apoptotic cell death. However,
a direct link between apoptosis and nucleolar break-
down has not yet been established. If nucleolar disas-
sembly can be seen in some apoptotic systems (Baran
et al., 2003), most studies have shown that both nucleo-
lar size and density do not change under apoptosis,
so that ‘‘on the whole, the nucleolus is regarded as a nu-
clear domain very resistant to apoptosis’’ (Martelli et al.,
2001). Apoptotis, therefore, seems an unlikely expla-
nation for nucleolar disruption in Ubc9 mutant cells.
The maintenance of the nucleolar organization relies on
the equilibrium between transcription, processing, and
export of the ribosomal subunits, and inactivation of one
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down. It is thus very likely that nucleolar disassembly
observed in Ubc9-deficient cells rather reflects global
defects in one or several of the events involved in ribo-
some production. Also, it is of note that several nucleolar
proteins, including RNA Pol-I, fibrillarin, nucleophosmin,
and some ribosomal proteins, were identified as puta-
tive SUMO susbstrates in proteome-wide studies (Panse
et al., 2004; Rosas-Acosta et al., 2005). It is thus possible
that lack of sumoylation of these targets plays a role in
nucleolar defects that occur in Ubc9-depleted embryos.
A major SUMO substrate, the PML protein, is a central
structural component of the PML Nuclear Bodies, the in-
tegrity of which is compromised in certain human dis-
eases (Borden, 2002). We show that lack of sumoylation
leads to a drastic mislocalization of PML and Daxx,
indicative of the disruption of its associated Nuclear
Bodies. These data are consistent with previous obser-
vations made in PML2/2 cells in which expression of
a sumoylation-deficient PML mutant fails to induce the
formation of Nuclear Bodies (Zhong et al., 2000). Alto-
gether, these data demonstrate that sumoylation is es-
sential for formation of the Nuclear Bodies. An intriguing
point is that many Nuclear Body-associated proteins are
SUMO modified, but whether, as for PML, sumoylation
is a requirement for Nuclear Body association is less
clear (Seeler and Dejean, 2003). While these structures
are not required for viability in mice (Wang et al., 1998),
they have been broadly involved in the control of cell
growth, transcription, and apoptosis (Borden, 2002). It
is thus tempting to speculate that disruption of Nuclear
Bodies and/or the subsequent release of nonsumoylated
associated factors in Ubc9-deficient embryos have im-
portant effects on these fundamental processes. In
this regard, the fact that Daxx is delocalized from the Nu-
clear Bodies in the absence of sumoylation may be par-
ticularly relevant because it has been implicated in apo-
ptosis (Salomoni and Pandolfi, 2002).
Implications for Nuclear Transport
in Ubc9-Deficient Cells
The first identified target for sumoylation, RanGAP1, pro-
vided a first link between nuclear transport and SUMO.
Conjugation to SUMO was shown to target cytosolic
RanGAP1 to the NPC RanBP2 protein, and this asso-
ciation is essential for nuclear trafficking (Mahajan
et al., 1998; Matunis et al., 1998). Whether sumoylated
RanGAP1 has to sit at the NPC for efficient transport re-
mains unclear, but the capacity of antibodies to block
nuclear import by inhibiting pore-associated RanGAP1
(Mahajan et al., 1997) strongly supports this idea.
RanGAP1 is known to stimulate the GTPase activity of
Ran, thus accelerating the conversion of RanGTP to
RanGDP. A striking feature of the Ran system is the
asymmetricdistributionof itsconstituents, includingRan
itself, between nucleus and cytoplasm. Ran is predomi-
nantly found in the nucleus, and a steep gradient exists
for RanGTP across the nuclear envelope (Gorlich and
Mattaj,1996;Pemberton andPaschal, 2005). The changes
we observed in Ran localization suggest that loss of
sumoylation may alter Ran cycling. One possibility is
that the absence of RanGAP1 at the NPC would account
for the increase in cytosolic RanGTP. It is also possible
that the lack of sumoylation of other transport factorsis involved. The collapse in the Ran gradient we observed
in Ubc9-deficient cells is expected to result in severe de-
fects in nuclear trafficking.
Another possible function of RanGAP1 sumoylation is
its participation in the mitotic functions of Ran. During
mitosis, RanGAP1 is diffusely distributed throughout
the cell, although a significant fraction localizes to the
mitotic spindles with accumulation at the kinetochores
(Joseph et al., 2002; Matunis et al., 1996). Because
SUMO modification is essential for RanGAP1 to be as-
sociated with spindles (Joseph et al., 2002), it is also
tempting to speculate that Ubc9-deficient cells exhibit
centromeric defects. Consistent with this notion, we
observed that, when compared to control cells, the en-
richment of RanGAP1 at kinetochores was absent in
Ubc9-deficient cells that had been fixed without digito-
nin permeabilization (unpublished data).
The studies described here demonstrate that sumoy-
lation contributes one or several essential function(s) for
early mammalian development. Impairment of this pro-
cess causes chromosome missegregation together with
major abnormalities in nuclear organization that results
in apoptotic cell death. It is likely that the loss of nuclear
architecture integrity and expected defects in nuclear
transport contribute to cell death. Definitive resolution
of these issues will await the development of conditional
inactivation systems from which appropriate material for
detailed mechanistic studies can be derived.
Experimental Procedures
Gene Targeting and Generation of Mutant Mice
Ubc9 genomic clones were isolated from a mouse 129/Sv genomic
library. To use the ‘‘flox-and-invert’’ strategy (Lam and Rajewsky,
1998; Roberts et al., 2002), an inverted SpeI-flanked loxP sequence
was inserted into an Xba I site upstream of exon 2, consequently de-
stroying this site. CJ7 embryonic stem (ES) cells were electropo-
rated, and transformed cells that survived G418 selection were
screened for homologous recombination by Southern blotting by
using a 50, a 30, and a Neo probe (see below). Three positive ES
cell clones were expanded and injected separately into C57BL6/J
blastocysts to generate chimeras. Chimeras were crossed with
C57BL6/J females to test the germline transmission of the Ubc9 tar-
geted allele (Ubc9t). Two Ubc9 homologous recombinant founder
lines were obtained (L134 and L196). Ubc9t/t males were mated with
PGK-Crem females (Lallemand et al., 1998) to generate Ubc9fl-inv/+/
PGK-Crem mice carrying both deletion of the neomycin transgene
and reversible inversion of exons 2 and 3. These mice were mated
to wild-type females in order to cross out the Cre allele. Ubc9inv/+
heterozygous mice carrying stabilized inverted allele were then in-
tercrossed to obtain Ubc9inv/inv embryos.
Genotyping
ES Cells, Embryos, and Animals
For Southern blot analysis, genomic DNA from cultured ES cells was
digested with EcoRI or XbaI and was hybridized with the indicated
50, 30 (Figures 1A and 1B), or Neo probes. For PCR analysis, genomic
DNA from tail clippings or whole embryos were used as template,
primer ‘‘a’’ was used either with primer ‘‘b’’ to amplify the wild-
type (+) (459 bp) and the floxed (fl) allele (537 bp), or with primer
‘‘c’’ to amplify the inverted (inv) allele (440 bp). (Figure 1A). Primers
and conditions for nested PCR are available upon request.
Immunoblotting
Cultured adult ear fibroblasts or freshly dissected testes were ex-
tracted in buffer (50 mM Tris HCl [pH 7.5], 150 mM NaCl, 10 mM
EDTA, 0.5% sodium deoxycholate, 1% Nonidet P40, 0.1% SDS,
20 mM N-ethyl maleimide [NEM], 1 mM dithiothreitol, 13 Protease
inhibitor cocktail tablets [Complete, Roche]). Western blots were
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778probed with antibodies against SUMO-1 (Zymed), SUMO-2/3 (rabbit
polyclonal antibody provided by M. Matunis), RanGAP1 (goat serum
provided by F. Melchior), PML (mouse polyclonal serum, provided
by P.G. Pelicci), or a-tubulin for loading controls (Santa Cruz).
Culture of Primary Adult Fibroblasts
Adult fibroblasts were established from ear skin biopsies from
Ubc9+/+ or Ubc9inv/+ mice as described (Me´met et al., 1997). Stress
and drug treatments were performed as described (Saitoh and Hin-
chey, 2000). Stimuli were: heat shock (10 min at 43ºC), osmotic
stress (normal medium plus 0.7 M NaCl for 15 min at 37ºC), oxidative
stress (100 mM H2O2 for 20 min at 37ºC), or exposure to 7% ethanol
(20 min at 37ºC). Control samples were left untreated.
Blastocyst Recovery and Outgrowth Cultures
4- to 6-week-old heterozygous Ubc9inv/+ females were superovu-
lated (5 IU of pregnant mare serum gonadotropin [Intervet Lab.], fol-
lowed 48 hr later by 5 IU of human chorionic gonadotropin [Intervet
Lab.]) and mated with heterozygous Ubc9inv/+ males. Females pos-
itive for the presence of the vaginal plug were sacrificed at 3.5 days
postcoitus, and blastocysts were collected by uterine flush and
grown on 0.1% gelatin-coated chambered slides (Lab-Tek) in ES
cell medium with antibiotics without leukemia inhibitory factor. Em-
bryo morphology was observed by phase contrast microscopy, and
blastocyst outgrowths were photographed each day. At the indi-
cated times, outgrowths were scraped off and lysed for genotyping
as described above.
TUNEL Assay and Immunofluorescence Studies
DNA fragmentation-associated cell death of cultured blastocysts
was detected by the TdT-mediated dUTP-fluorescein nick end label-
ing (TUNEL) assay by using the In Situ Cell Death Detection kit, Pod
(Roche), and the manufacturer’s protocol. Embryos were observed
by phase contrast and fluorescence microscopy; green-stained nu-
clei were counted as TUNEL-positive cells. For immunofluorescence
analysis, embryos were fixed in 4% PFA for 10 min; permeabilized
with 0.25% Triton X-100 for 10 min; incubated with antibodies
against lamin B1 (affinity-purified rabbit serum, provided by J.C.
Courvalin), fibrillarin (purified human autoimmune serum A68, pro-
vided by D. Hernandez-Verdun), SUMO-1 (Zymed), PML (Upstate),
Daxx (Santa Cruz), RanGAP1 (goat serum provided by F. Melchior),
and Ran (BD Transduction Laboratories); and then incubated with
appropriate secondary antibodies (Biorad, Molecular probes). Slides
were mounted in VectaShield containing DAPI (Vector Laboratories).
Structured illumination fluorescent images (optical sections) were
acquired with a Zeiss Axiocam HRc camera (Zeiss Axiovision
4.1 software) on an Axioplan 2 imaging microscope-equipped
ApoTome system (Zeiss). After TUNEL assay or immunofluores-
cence analysis, embryos were recovered and lysed for genotyping.
Preparation of Mitotic Spreads
E3.5 blastocysts were cultured for 42 hr, treated with 2.5 mM noco-
dazole for 6 hr, processed for preparation of mitotic spreads as de-
scribed by Brown (2004), and modified as follows: step 2, blastocyst
cultures were trypsinized by adding 30 ml 0.5% trypsin/1 mM EDTA
and incubated at 37ºC for 15 min; and step 7, cells were rinsed once
in 200 ml 75 mM KCl before hypotonic shock to allow for the com-
plete removal of PBS salt. Images were taken as described above.
A total of 50 ml cell suspension from step 4 was washed twice with
PBS and lysed for genotyping.
Supplemental Data
Supplemental Data including one figure are available at http://
www.developmentalcell.com/cgi/content/full/9/6/769/DC1/.
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